Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 8 of 37
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By
Lauran Neergaard
and
The Associated Press
January 3, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By
Jeremy Kahn
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
December 27, 2021
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By
Matthew Perrone
and
The Associated Press
December 22, 2021
Health
Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By
David Meyer
December 22, 2021
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
,
Robert Langreth
and
Bloomberg
December 21, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By
Christiaan Hetzner
December 20, 2021
Health
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By
Christiaan Hetzner
December 17, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Bernhard Warner
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Health
Germany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines
By
Christiaan Hetzner
December 15, 2021
Health
Pfizer pill reduces risk of COVID hospitalization and death by 89%, and should protect against Omicron
By
Kylie Logan
December 14, 2021
Most Popular
Economy
Two months into the new fiscal year and the U.S. government is already spending more than $10 billion a week servicing...
By
Eleanor Pringle
Success
‘Godfather of AI’ says Bill Gates and Elon Musk are right about the future of work—but he predicts mass unemployment is...
By
Preston Fore
Success
Nvidia CEO Jensen Huang admits he works 7 days a week, including holidays, in a constant 'state of anxiety' out of fear...
By
Jessica Coacci